FDA Inspection 1204031 — American Red Cross-Myrtle Beach

American Red Cross-Myrtle Beach — FEI 3000207047

The FDA completed an inspection of American Red Cross-Myrtle Beach on April 6, 2023 in Myrtle Beach, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 6, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Myrtle Beach, SC (United States)